These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25389781)

  • 21. The expression of GHRH and its receptors in breast carcinomas with apocrine differentiation-further evidence of the presence of a GHRH pathway in these tumors.
    Kővári B; Vranic S; Marchio C; Sapino A; Cserni G
    Hum Pathol; 2017 Jun; 64():164-170. PubMed ID: 28438614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemically defined subtypes and outcome of apocrine breast cancer.
    Dellapasqua S; Maisonneuve P; Viale G; Pruneri G; Mazzarol G; Ghisini R; Mazza M; Iorfida M; Rotmensz N; Veronesi P; Luini A; Goldhirsch A; Colleoni M
    Clin Breast Cancer; 2013 Apr; 13(2):95-102. PubMed ID: 23245877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coordinated expression of oestrogen and androgen receptors in HER2-positive breast carcinomas: impact on proliferative activity.
    Lin Fde M; Pincerato KM; Bacchi CE; Baracat EC; Carvalho FM
    J Clin Pathol; 2012 Jan; 65(1):64-8. PubMed ID: 22039288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical and molecular profiling of histologically defined apocrine carcinomas of the breast.
    Vranic S; Marchiò C; Castellano I; Botta C; Scalzo MS; Bender RP; Payan-Gomez C; di Cantogno LV; Gugliotta P; Tondat F; di Celle PF; Mariani S; Gatalica Z; Sapino A
    Hum Pathol; 2015 Sep; 46(9):1350-9. PubMed ID: 26208846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of FABP7 promotes cell growth and predicts poor prognosis of clear cell renal cell carcinoma.
    Zhou J; Deng Z; Chen Y; Gao Y; Wu D; Zhu G; Li L; Song W; Wang X; Wu K; He D
    Urol Oncol; 2015 Mar; 33(3):113.e9-17. PubMed ID: 25192834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pure Apocrine Carcinomas Represent a Clinicopathologically Distinct Androgen Receptor-Positive Subset of Triple-Negative Breast Cancers.
    Mills AM; E Gottlieb C; M Wendroth S; M Brenin C; Atkins KA
    Am J Surg Pathol; 2016 Aug; 40(8):1109-16. PubMed ID: 27259012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Update on the Molecular and Clinical Characteristics of Apocrine Carcinoma of the Breast.
    Vranic S; Gatalica Z
    Clin Breast Cancer; 2022 Jun; 22(4):e576-e585. PubMed ID: 35027319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of oestrogen receptor-beta in apocrine carcinomas of the breast.
    Honma N; Takubo K; Akiyama F; Kasumi F; Sawabe M; Arai T; Hosoi T; Yoshimura N; Harada N; Younes M; Sakamoto G
    Histopathology; 2007 Mar; 50(4):425-33. PubMed ID: 17448017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fine needle aspiration cytology of apocrine carcinoma of the breast. Review of cases in a three-year period.
    Ng WK
    Acta Cytol; 2002; 46(3):507-12. PubMed ID: 12040645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of C-KIT, CD24, CD44s, and COX2 in benign and non-invasive apocrine lesions of the breast.
    Tramm T; Kim JY; Leibl S; Moinfar F; Tavassoli FA
    Virchows Arch; 2016 Sep; 469(3):285-95. PubMed ID: 27287269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer.
    Zhang H; Rakha EA; Ball GR; Spiteri I; Aleskandarany M; Paish EC; Powe DG; Macmillan RD; Caldas C; Ellis IO; Green AR
    Breast Cancer Res Treat; 2010 May; 121(1):41-51. PubMed ID: 19590950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apocrine cysts of the breast: biomarkers, origin, enlargement, and relation with cancer phenotype.
    Celis JE; Gromov P; Moreira JM; Cabezón T; Friis E; Vejborg IM; Proess G; Rank F; Gromova I
    Mol Cell Proteomics; 2006 Mar; 5(3):462-83. PubMed ID: 16316978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative study of monoclonal antibody B72.3 and gross cystic disease fluid protein-15 as markers of apocrine carcinoma of the breast.
    Honma N; Takubo K; Arai T; Younes M; Kasumi F; Akiyama F; Sakamoto G
    APMIS; 2006 Oct; 114(10):712-9. PubMed ID: 17004974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fatty acid binding protein 7 as a marker of glioma stem cells.
    Morihiro Y; Yasumoto Y; Vaidyan LK; Sadahiro H; Uchida T; Inamura A; Sharifi K; Ideguchi M; Nomura S; Tokuda N; Kashiwabara S; Ishii A; Ikeda E; Owada Y; Suzuki M
    Pathol Int; 2013 Nov; 63(11):546-53. PubMed ID: 24274717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular and diagnostic features of apocrine breast lesions.
    Gromov P; Espinoza JA; Gromova I
    Expert Rev Mol Diagn; 2015; 15(8):1011-22. PubMed ID: 26111757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracytoplasmic lipid accumulation in apocrine carcinoma of the breast evaluated with adipophilin immunoreactivity: a possible link between apocrine carcinoma and lipid-rich carcinoma.
    Moritani S; Ichihara S; Hasegawa M; Endo T; Oiwa M; Shiraiwa M; Nishida C; Morita T; Sato Y; Hayashi T; Kato A
    Am J Surg Pathol; 2011 Jun; 35(6):861-7. PubMed ID: 21566511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apocrine carcinoma of the breast: a comprehensive review.
    Vranic S; Schmitt F; Sapino A; Costa JL; Reddy S; Castro M; Gatalica Z
    Histol Histopathol; 2013 Nov; 28(11):1393-409. PubMed ID: 23771415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apocrine carcinomas of the breast in Turkish women: hormone receptors, c-erbB-2 and p53 immunoexpression.
    Kaya H; Bozkurt SU; Erbarut I; Djamgoz MB
    Pathol Res Pract; 2008; 204(6):367-71. PubMed ID: 18342452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uroplakin II Expression in Breast Carcinomas Showing Apocrine Differentiation: Putting Some Emphasis on Invasive Pleomorphic Lobular Carcinoma as a Potential Mimic of Urothelial Carcinoma at Metastatic Sites.
    Tajima S; Koda K
    Dis Markers; 2016; 2016():2940496. PubMed ID: 27642214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD10 Immunohistochemical Expression in Apocrine Lesions of the Breast.
    Kővári B; Báthori Á; Cserni G
    Pathobiology; 2015; 82(6):259-63. PubMed ID: 26562027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.